Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024
Xtant Medical Holdings (NYSE American: XTNT) announced it will release its third quarter 2024 financial results on November 12, 2024, after market close. The company will host a conference call at 4:30 PM ET the same day, featuring President and CEO Sean Browne and CFO Scott Neils. The call will be accessible via phone and webcast, with a replay available on the company's website afterward.
Xtant Medical Holdings (NYSE American: XTNT) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 il 12 novembre 2024, dopo la chiusura del mercato. La società terrà una conferenza telefonica alle 16:30 ET nello stesso giorno, con il Presidente e CEO Sean Browne e il CFO Scott Neils. La chiamata sarà accessibile tramite telefono e webcast, con una registrazione disponibile sul sito web della società successivamente.
Xtant Medical Holdings (NYSE American: XTNT) anunció que publicará sus resultados financieros del tercer trimestre de 2024 el 12 de noviembre de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a las 4:30 PM ET el mismo día, con el Presidente y CEO Sean Browne y el CFO Scott Neils. La llamada será accesible por teléfono y webcast, y se podrá escuchar una grabación en el sitio web de la empresa posteriormente.
Xtant Medical Holdings (NYSE American: XTNT)는 2024년 11월 12일 시장 마감 후 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 4시 30분 ET에 회의를 개최할 예정이며, 회의에는 회장 겸 CEO인 Sean Browne와 CFO인 Scott Neils가 참석합니다. 이 통화는 전화와 웹캐스트를 통해 접근 가능하며, 이후 회사 웹사이트에서 재생할 수 있습니다.
Xtant Medical Holdings (NYSE American: XTNT) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le 12 novembre 2024, après la clôture des marchés. L'entreprise organisera une conférence téléphonique à 16h30, HE, le même jour, avec le Président et CEO Sean Browne et le CFO Scott Neils. L'appel sera accessible par téléphone et par webdiffusion, avec un enregistrement disponible sur le site web de l'entreprise par la suite.
Xtant Medical Holdings (NYSE American: XTNT) gab bekannt, dass es seine Finanzergebnisse für das dritte Quartal 2024 am 12. November 2024 nach Handelsende veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz abhalten, an der Präsident und CEO Sean Browne sowie CFO Scott Neils teilnehmen werden. Die Konferenz kann telefonisch und per Webcast verfolgt werden, und eine Aufzeichnung wird anschließend auf der Website des Unternehmens verfügbar sein.
- None.
- None.
BELGRADE, MT / ACCESSWIRE / November 7, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2024, after the close of the financial markets on Tuesday, November 12, 2024.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Tuesday, November 12, 2024 at 4:30 PM ET to review results.
Conference Details:
Conference Date: Tuesday, November 12, 2024
Conference Time: 4:30 PM ET
Conference dial-in: 888-999-3182
International dial-in: 848-280-6330
Passcode: Xtant Medical Holdings
Conference Call Name: Xtant Medical Q3 2024 Financial Results
Webcast Link: https://www.webcaster4.com/Webcast/Page/3039/51623
Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor Info."
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact:
Brett Maas
Managing Partner
Hayden IR
brett@haydenir.com
(646) 536-7331
SOURCE: Xtant Medical Holdings, Inc.
View the original press release on accesswire.com
FAQ
When will Xtant Medical (XTNT) release Q3 2024 earnings?
How can I access Xtant Medical's (XTNT) Q3 2024 earnings call?
Who will host Xtant Medical's (XTNT) Q3 2024 earnings call?
